Column Group Opportunity III GP, LP, 10% Owner, Director at NGM BIOPHARMACEUTICALS INC (NGM), bought 247,640 shares at $4.75 ($1.2M) on 2022-10-25, disclosed to the SEC on 2022-10-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.75 | 51,046 | $242K | 20.4% |
| 2 | $4.75 | 51,046 | $242K | 20.4% |
| 3 | $4.85 | 72,774 | $353K | 29.6% |
| 4 | $4.85 | 72,774 | $353K | 29.6% |
| Total | $4.81 avg | 247,640 | $1.2M | 100% |